Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

[Present research on the status and the prospect of insulin-like growth factor-I in head and neck cancer].

Liu X, Jiang L.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012 Aug;26(15):717-20. Review. Chinese.

PMID:
23167189
2.

Insulin-like growth factor binding protein-5 (IGFBP-5) suppresses the tumourigenesis of head and neck squamous cell carcinoma.

Hung PS, Kao SY, Shih YH, Chiou SH, Liu CJ, Chang KW, Lin SC.

J Pathol. 2008 Feb;214(3):368-76.

PMID:
18085517
3.

Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.

Barnes CJ, Ohshiro K, Rayala SK, El-Naggar AK, Kumar R.

Clin Cancer Res. 2007 Jul 15;13(14):4291-9.

4.

Insulin-like growth factors and cancer.

Yu H, Berkel H.

J La State Med Soc. 1999 Apr;151(4):218-23. Review.

PMID:
10234899
6.

Insulin-like growth factor-binding protein-6 and cancer.

Bach LA, Fu P, Yang Z.

Clin Sci (Lond). 2013 Feb;124(4):215-29. doi: 10.1042/CS20120343. Review.

PMID:
23126425
7.
8.

The insulin-like growth factor system and cancer.

LeRoith D, Roberts CT Jr.

Cancer Lett. 2003 Jun 10;195(2):127-37. Review.

PMID:
12767520
9.
10.

Insulin-like growth factor 1 and hair growth.

Su HY, Hickford JG, Bickerstaffe R, Palmer BR.

Dermatol Online J. 1999 Nov;5(2):1.

PMID:
10673454
11.

Insulin-like growth factors induce apoptosis as well as proliferation in LIM 1215 colon cancer cells.

Fu P, Thompson JA, Leeding KS, Bach LA.

J Cell Biochem. 2007 Jan 1;100(1):58-68.

PMID:
16888814
12.
13.

Effect of lycopene on insulin-like growth factor-I, IGF binding protein-3 and IGF type-I receptor in prostate cancer cells.

Kanagaraj P, Vijayababu MR, Ravisankar B, Anbalagan J, Aruldhas MM, Arunakaran J.

J Cancer Res Clin Oncol. 2007 Jun;133(6):351-9. Epub 2007 Jan 12.

PMID:
17219202
14.

c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potential.

Wu X, Zhou J, Rogers AM, Jänne PA, Benedettini E, Loda M, Hodi FS.

Melanoma Res. 2012 Apr;22(2):123-32. doi: 10.1097/CMR.0b013e3283507ffd.

PMID:
22343486
15.
16.

Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling.

Shen MR, Hsu YM, Hsu KF, Chen YF, Tang MJ, Chou CY.

Carcinogenesis. 2006 May;27(5):962-71. Epub 2006 Jan 7.

PMID:
16400188
17.

Insulin-like growth factor I receptor involvement in proliferation of NOR-P1 cells in serum-free media.

Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T.

J Cell Biochem. 2012 Aug;113(8):2714-20. doi: 10.1002/jcb.24149.

PMID:
22441995
18.

Insulin-like growth factor-I and cancer risk.

Ibrahim YH, Yee D.

Growth Horm IGF Res. 2004 Aug;14(4):261-9. Review.

PMID:
15231294
19.

Regulation of vascular smooth muscle cell responses to insulin-like growth factor (IGF)-I by local IGF-binding proteins.

Hsieh T, Gordon RE, Clemmons DR, Busby WH Jr, Duan C.

J Biol Chem. 2003 Oct 31;278(44):42886-92. Epub 2003 Aug 12.

20.

Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis.

Jenkins PJ, Khalaf S, Ogunkolade W, McCarthy K, David T, Hands RE, Davies D, Bustin SA.

Endocr Relat Cancer. 2005 Dec;12(4):891-901.

Supplemental Content

Support Center